Search Results - Kate Hanrott
- Showing 1 - 1 results of 1
-
1
An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arter... by Marc A. Simon, Kate Hanrott, David C. Budd, Fernando Torres, Ekkehard Grünig, Pilar Escribano‐Subias, Manuel L. Meseguer, Michael Halank, Christian Opitz, David A. Hall, Deborah Hewens, William M. Powley, Sarah Siederer, Andrew Bayliffe, Aili L. Lazaar, Anthony Cahn, Stephan Rosenkranz
Published in Pulmonary Circulation (2022-01-01)Get full text
Article
